Recombinant Mouse Anti-HEV genotype 1 Antibody (8C11) (CAT#: PABL-130)

Recombinant Mouse Antibody (8C11) is capable of binding to neutralizing conformational epitope on HEV genotype I, expressed in Chinese Hamster Ovary cells (CHO). This antibody could block the virus-like particle from binding to and penetrating the host cell.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA

Figure 1 Mutational studies on the dimer interface

Figure 1 Mutational studies on the dimer interface

(A) The schematic representation of wild-type E2 and eleven point mutations targeting the dimer interface region. Secondary structural elements are shown for the E2s region. The mutated residues located on the b-strands and coils are shown in red and black, respectively. (B) These mutants and wild-type E2 were subjected to non-reducing SDS-PAGE and Western Blotting with the neutralizing mAb 8C11 and 8H3 to study the effects of these mutations on dimerization and neutralization, respectively. [+] denotes dimerization or reactivity with 8C11 or 8H3, denotes loss of the respective property. Note that both the capacity to form dimers and the reactivity with mAb 8C11 and 8H3 were abolished simultaneously in six of these mutants: Y557A, T564A, V598E, A599E, L601E and A602E.

Li, S., Tang, X., Seetharaman, J., Yang, C., Gu, Y., Zhang, J.,... & Xia, N. (2009). Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus–host interaction.PLoS pathogens, 5(8), e1000537.

Figure 2 Mutational studies on the groove region.

Figure 2 Mutational studies on the groove region.

(A) The schematic representation of wild-type E2 and nine point mutations targeting the solvent-accessible residues near the groove region. (B) The wild type E2 and its mutants were subjected to non-reducing SDS-PAGE and Western Blotting with the HEV-neutralizing antibody 8C11 or 8H3. In this figure the lanes with H indicate samples in the reduced condition (i.e. these samples were heated up to 100uC for 3 minutes). These samples were mainly resolved as monomers. The lanes with N indicate samples in the non-reducing condition (i.e. these samples with 0.1% SDS, no BME and were not heated). These samples were resolved mainly as dimers. All nine mutants remained as dimers. Western Blotting showed that the dimeric E2 wild type and eight mutants were reactive with mAb 8C11. Of these, only E479A, Y485A, I529A, K534A and D496A abolished the 8H3 reactivity. Interestingly, mutant D496A abolished the HEV neutralizing antibodies 8C11 and 8H3 reactivity while maintaining the dimeric arrangement.

Li, S., Tang, X., Seetharaman, J., Yang, C., Gu, Y., Zhang, J.,... & Xia, N. (2009). Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus–host interaction.PLoS pathogens, 5(8), e1000537.

Figure 4 (A and B) The mutants and wild-type E2 were subjected to nonreducing SDS/ PAGE and Western blotting with the neutralizing mAb 8C11 to study the effects of these mutations on E2s(I):8C11 interaction.

Figure 4 (A and B) The mutants and wild-type E2 were subjected to nonreducing SDS/ PAGE and Western blotting with the neutralizing mAb 8C11 to study the effects of these mutations on E2s(I):8C11 interaction.

The lanes marked with H indicate heated samples in the reduced condition (i.e., these samples were heated up to 100 °C for 3 min) and the lanes marked with N indicate samples in the nonreducing condition (i.e., these samples with 0.1% SDS, no β-mercaptoethanol, and were not heated). (+) Denotes dimerization or reactivity with 8C11, (−) denotes monomer or loss of the respective property.

Tang, X., Yang, C., Gu, Y., Song, C., Zhang, X., Wang, Y.,... & Sivaraman, J. (2011). Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proceedings of the National Academy of Sciences, 108(25), 10266-10271.

Figure 5 (C–E) Sedimentation velocity (SV) was used to detect the mAb 8C11 binding of E2s(I) (C), and the mutants Arg512Ala (D) and Arg512Glu (E).

Figure 5 (C–E) Sedimentation velocity (SV) was used to detect the mAb 8C11 binding of E2s(I) (C), and the mutants Arg512Ala (D) and Arg512Glu (E).

The c(s) profile of E2, its mutants, or mAb 8C11 alone was denoted as a dashed curve. The profile of the antigen-antibody mixtures was drawn in a solid line. Molar ratio of E2 or its mutant versus mAb 8C11 was 5:1, meaning the antigen was in surplus.

Tang, X., Yang, C., Gu, Y., Song, C., Zhang, X., Wang, Y.,... & Sivaraman, J. (2011). Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proceedings of the National Academy of Sciences, 108(25), 10266-10271.


Specifications

  • Immunogen
  • Hepatitis E virus Hepatitis E
  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • IgG
  • Specificity
  • Tested positive against native HEV HEV
  • Species Reactivity
  • HEV
  • Clone
  • 8C11
  • Applications
  • WB, ELISA, IF, FuncS

Product Property

  • Purity
  • >95% by SDS-PAGE and HPLC analysis
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • For Western Blotting experiments, separated proteins were transferred from an SDS gel onto a nitrocellulose membrane. Membranes were soaked in 1:2,000 diluted HEV-neutralizing monoclonal antibody 8C11, incubated at room temperature for 1 h, and subsequently washed with 0.2% Tween 20 in phosphate-buffered saline (at pH 7.4). The bound antibody was detected with alkaline phosphatase conjugated secondary antibody (DAKO), and developed with a mixture of nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.

Target

  • Alternative Names
  • Hepatitis E; HEV

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 8C11"

See other products for "HEV"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for PABL-130. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare